Zoetis Inc. Class A ($ZTS) Stock Forecast: Down 5.0% Today

What is Zoetis Inc. Class A?

Zoetis (ZTS) is a leading global animal health company specializing in veterinary vaccines and medicines, with operations in over 100 countries and a diverse product portfolio for livestock and companion animals.

Why is Zoetis Inc. Class A going down?

ZTS stock is down 5.0% on May 6, 2025 18:56

• Despite surpassing earnings and revenue expectations in Q1 and revising upwards its 2025 guidance, Zoetis (ZTS) faced a downward market trend.
• The market's negative reaction to the raised tariffs outlined in the updated 2025 guidance has led to investor uncertainty.
• The stock's decline over the last year, with a slight uptick in the most recent session, may also be influencing the prevailing bearish outlook.
• Investors could be delving deeper than headline figures and core metrics to evaluate Zoetis's long-term growth prospects, resulting in cautious trading activities.

ZTS Price Chart

ZTS Technical Analysis

ZTS News

Zoetis Q1 Earnings & Revenues Beat Estimates, '25 Outlook Raised

ZTS reports better-than-expected first-quarter results as earnings and revenues surpass estimates. Management raises 2025 guidance.

https://www.zacks.com/stock/news/2463294/zoetis-q1-earnings-revenues-beat-estimates-25-outlook-raised

Zoetis Beats Wall Street Estimates, Revises 2025 Guidance To Include Tariffs Impact - Zoetis ( NYSE:ZTS )

Q1 adjusted EPS was $1.48 vs. $1.39 consensus; revenue rose to $2.22 billion, up 1% Y/Y and beating estimates. Zoetis raised FY2025 adjusted EPS guidance to $6.20-$6.30, above previous range and consensus of $6.09. Feel unsure about the market's next move?

https://www.benzinga.com/25/05/45225594/zoetis-q1-earnings-beats-wall-street-estimates-revises-2025-guidance-to-include-tariffs-impact

Zoetis ( ZTS ) Surpasses Q1 Earnings and Revenue Estimates

Zoetis (ZTS) delivered earnings and revenue surprises of 5.71% and 1.35%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

https://www.zacks.com/stock/news/2462752/zoetis-zts-surpasses-q1-earnings-and-revenue-estimates

P/E Ratio Insights for Zoetis - Zoetis ( NYSE:ZTS )

Looking into the current session, Zoetis Inc. ZTS shares are trading at $158.35, after a 1.73% increase. Moreover, over the past month, the stock spiked by 3.76%, but in the past year, decreased by 5.13%.

https://www.benzinga.com/insights/news/25/05/45179721/pe-ratio-insights-for-zoetis

Zoetis ( ZTS ) Q1 Earnings Preview: What You Should Know Beyond the Headline Estimates

Get a deeper insight into the potential performance of Zoetis (ZTS) for the quarter ended March 2025 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

https://www.zacks.com/stock/news/2459974/zoetis-zts-q1-earnings-preview-what-you-should-know-beyond-the-headline-estimates

Trending Today

Zoetis Inc. Class A Price History

19.08.2024 - ZTS Stock was down 1.7%

• The bearish movement in ZTS stock today could be attributed to profit-taking by investors after a recent 15% rise in the stock price over the past 3 months.
• The mixed performance of ZTS compared to the overall market might have led some investors to reevaluate their positions in the stock.
• The comparison between ZTS and SDZNY for better value might have also influenced investor sentiment, potentially causing some to shift their investments away from ZTS.
• Despite the positive outlook for ZTS with its innovative products and business expansion efforts, short-term market dynamics and profit considerations could have driven the bearish movement in the stock today.

06.10.2024 - ZTS Stock was down 2.3%

• Despite reporting strong Q3 earnings and revenue beats, Zoetis' stock experienced a bearish movement.
• The market may have reacted negatively due to profit-taking by investors after a period of sustained growth.
• The comparison with other value stocks like SDZNY might have influenced some investors to shift their positions, impacting Zoetis' stock price.
• Overall, the bearish movement could be a short-term correction in response to recent positive news, presenting a potential buying opportunity for investors bullish on Zoetis' long-term prospects.

04.11.2024 - ZTS Stock was down 0.1%

• The bearish movement in ZTS could be attributed to profit-taking by investors after a period of sustained growth in the stock.
• The bullish note on Autodesk and other companies may have diverted investor attention away from ZTS, leading to a lack of buying interest and contributing to the downward pressure on the stock.
• Analyst initiations on other companies might have overshadowed ZTS, causing a shift in focus and resulting in the bearish movement observed today.
• Overall, the market movement in ZTS could be a combination of internal profit-taking and external factors drawing investor interest elsewhere.

30.04.2024 - ZTS Stock was down 1.0%

• Zoetis (ZTS) stock showed a downward trend today.
• Concerns regarding the effects of arthritis medications on animals have impacted ZTS stock negatively.
• Ongoing examinations by legal entities and financial consultants concerning potential issues in Q1 have added to investor apprehension.
• The prevailing pessimism surrounding Zoetis possibly influenced the bearish market behavior witnessed today.

06.04.2025 - ZTS Stock was down 5.0%

• Despite surpassing earnings and revenue expectations in Q1 and revising upwards its 2025 guidance, Zoetis (ZTS) faced a downward market trend.
• The market's negative reaction to the raised tariffs outlined in the updated 2025 guidance has led to investor uncertainty.
• The stock's decline over the last year, with a slight uptick in the most recent session, may also be influencing the prevailing bearish outlook.
• Investors could be delving deeper than headline figures and core metrics to evaluate Zoetis's long-term growth prospects, resulting in cautious trading activities.

27.05.2024 - ZTS Stock was up 6.3%

• The bullish movement in ZTS today can be attributed to:
• The overall positive sentiment towards biotech and pharmaceutical stocks, emphasizing the growth potential and value of companies in these sectors.
• The increasing focus on healthcare and biotechnology sectors as investors potentially rotate away from tech stocks, leading to a surge in interest and investment in companies like Zoetis Inc.
• The mention of the Dog Vitamins Market growth potential indirectly benefiting companies like Zoetis Inc., which operates in the animal health industry and could see increased demand for its products in the future.

06.07.2024 - ZTS Stock was up 5.3%

• The company reported its financial results for the second quarter of 2024, exceeding estimates and raising its guidance for the full year 2024.
• Revenue for the second quarter of 2024 increased by 8% compared to the same period last year, showcasing strong operational growth.
• Analysts raised their target for Zoetis shares, reflecting a positive outlook on the company's performance and potential.
• Despite a declining market, Zoetis stock advanced, indicating investor confidence in the company's financial health and growth prospects.

06.07.2024 - ZTS Stock was up 5.1%

• Zoetis (ZTS) experienced a strong bullish movement today.
• The surge in stock price can be attributed to the company's impressive Q2 earnings performance, surpassing both earnings and revenue estimates.
• The positive market reaction was further fueled by Zoetis raising its outlook for 2024, indicating strong confidence in future performance.
• The beat-and-raise quarter showcased Zoetis' ability to capitalize on the growing demand for companion animal products, driving investor optimism and pushing the stock higher.

06.07.2024 - ZTS Stock was up 5.2%

• Zoetis reported better-than-expected second-quarter financial results and raised its 2024 guidance, instilling confidence in investors.
• The company beat earnings per share and revenue estimates for Q2 2024, driven by strong sales of companion animal products.
• The market reacted positively to Zoetis' "beat-and-raise" quarter, where the company exceeded expectations and provided an optimistic outlook for the future.
• Overall, the bullish movement in ZTS stock can be attributed to the company's solid performance and optimistic guidance, showcasing its resilience and growth potential in the animal health industry.

13.01.2025 - ZTS Stock was down 9.2%

• The bearish movement in ZTS stock today may be due to profit-taking by investors ahead of the company's upcoming Q4 earnings report. Despite positive performance metrics and anticipated earnings growth on Wall Street, market uncertainty could be causing this downward trend. Investors seem to be adopting a cautious approach, possibly concerned about meeting or surpassing high estimates.

13.01.2025 - ZTS Stock was down 7.1%

• Despite exceeding Q4 earnings and revenue estimates, Zoetis (ZTS) experienced a decrease in its stock price due to its 2025 guidance falling short of expectations.
• Investors appeared displeased with the projected revenue range of $9.225B-$9.375B for 2025, which was lower than market estimates.
• The market's response indicates that although the company performed well in the recent quarter, concerns regarding its future growth projections and guidance resulted in the decline.
• Emphasizing key metrics and Wall Street projections did not completely alleviate investor apprehensions about Zoetis' long-term prospects, contributing to the stock's downward trajectory.

04.03.2025 - ZTS Stock was down 5.0%

• Zoetis (ZTS) stock experienced a bearish movement of -1.16% today.
• The slight decline in ZTS stock could be attributed to profit-taking by investors after a recent bullish run.
• Market sentiment may have been influenced by broader economic factors or sector-specific news impacting the animal health industry.
• Investors might be closely monitoring upcoming developments or earnings reports from Zoetis to reassess their positions in the stock.